Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
- Submitting institution
-
University of Newcastle upon Tyne
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 253090-63211-1268
- Type
- D - Journal article
- DOI
-
10.1016/S0140-6736(18)32752-1
- Title of journal
- The Lancet
- Article number
- -
- First page
- 51
- Volume
- 393
- Issue
- 10166
- ISSN
- 0140-6736
- Open access status
- Compliant
- Month of publication
- November
- Year of publication
- 2018
- URL
-
https://doi.org/10.1016/S0140-6736(18)32752-1
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
31
- Research group(s)
-
C - Dentistry
- Citation count
- 240
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- a. The author made a substantial contribution to the organisation of the conduct of the study b. The author helped draft the output
- Non-English
- No
- English abstract
- -
